Increasing susceptibility of patients towards chronic diseases such as cardiovascular, neurological, oncology and respiratory diseases coupled with increasing R&D spending opening new application avenues is expected to drive market growth over the next six years. Other drivers of this market include increasing government and private sector R&D aid and new players entering the market to bridge the gap between supply and demand.
Clinical oncology nanotechnology applications dominated the overall market in 2013, accounting for 35% of total market revenue. Higher efficacy of nanomaterials and the ability of engineered nanoparticles to cross through the blood brain barrier provides platform for groundbreaking innovations through R&D in the field of cancer therapy and serves this market as a high impact rendering driver.
For more information on “Healthcare Nanotechnology (Nanomedicine) Market”, visit here: http://www.radiantinsights.com/research/healthcare-nanotechnology-nanomedicine-market-analysis-by-application-drug-delivery-system-molecular-diagnostics-clinical-oncology-clinical-neurology-clinical-cardiology-anti-inflammatory-anti-infective-and-segment-forecasts-to-2020
Further key findings from the study suggest:
- North America was the largest regional market in 2013, accounting for over 38% of global revenue on account of the extensive investments in research and development of innovative cancer therapies.
- Asia Pacific owing to its improving healthcare infrastructure and healthcare R&D spending is expected to grow at the highest CAGR of over 14.0% from 2014 to 2020.
- Moreover, emerging markets such as China and India hold a large amount of untapped opportunities and are therefore expected to fuel future market growth.
- Cardiovascular applications are expected to be the fastest growing segment for this market, owing to the growing global prevalence of cardiovascular diseases.
For more reports of this category, click here: http://www.radiantinsights.com/catalog/biotechnology
Table of Contents
Chapter 1. Executive Summary
Chapter 1. Executive Summary
1.1. Nanotechnology Healthcare - Industry Summary & Critical Success Factors (CSFs)
Chapter 2. Nanotechnology Healthcare Industry Outlook
2.1. Market Segmentation
2.2. Market Size and Growth Prospects
2.3. Nanotechnology Healthcare Market Dynamics
2.3.1. Market Driver Analysis
2.3.1.1. Growing incidences of chronic severe diseases
2.3.1.2. Technological innovation in medical application of nanotechnology
2.3.1.3. Growing geriatric population base
2.4. Key Opportunities Prioritized
2.5. Industry Analysis - Porter's
2.6. Nanotechnology Healthcare market PESTEL Analysis, 2013
About Radiant Insights
Radiant Insights is a platform for companies looking to meet their market research and business intelligence requirements. It assist and facilitate organizations and individuals procure market research reports, helping them in the decision making process. The Organization has a comprehensive collection of reports, covering over 40 key industries and a host of micro markets. In addition to over extensive database of reports, experienced research coordinators also offer a host of ancillary services such as, research partnerships/ tie-ups and customized research solutions.
For more information, Visit: http://www.radiantinsights.com/
Media Contact:
Company Name: Radiant Insights, Inc
Contact Person: Michelle Thoras
Email: sales@radiantinsights.com
Phone: (415) 349-0054
Address: 28 2nd Street, Suite 3036
City: San Francisco
State: California
Country: United States
No comments:
Post a Comment